Episode 5 - RIchard Shah and Navigating Global Life Science Projects

Our guest in this episode is Richard Shah. Richard currently serves as a Project Director and heads up the US Global Engineering Dept at WuXi Biologics.

In this conversation on Design, Build and Deliver with Hart Companies with host Samir Gondalia, Richard shares his journey from being a chemist to leading global life science projects. He discusses the nuances of managing projects across different regions, the importance of site selection, and the evolving conversation around speed to market in the pharmaceutical industry. Richard also highlights the design drivers for biopharma facilities and the future technologies that will shape the industry, including the role of AI and digitalization. The discussion concludes with personal insights and reflections on the industry.

Takeaways
- Richard's transitioned from a chemist to a global engineering leader.
- Site selection involves multiple factors including tax incentives and labor market.
- Speed to market has become a critical focus post-COVID.
- Design drivers for biopharma include ESG, single-use technology, and digitalization.
- Flexibility and future-proofing are essential in facility design.
- Cost differentials exist between construction in the US and Ireland.
- Single-use technologies are preferred for speed and flexibility.
- Richard emphasizes the importance of continuous learning and adaptation.

Quotable quotes:
"Flexibility and future proofing are key."
"Good data is confidential."

Whether you are a global life science facilities leader or an industry follower, this episode is full of real-world insights and implementable tips.

The links to the various platforms are in comments.